董事会 经核查独立董事楼佩煌、罗来千、许冬冬的任职经历以及签署的相关自查文 件，上述人员未在公司担任除独立董事以外的任何职务，也未在公司主要股东公 司担任任何职务，与公司以及主要股东、实际控制人之间不存在利害关系或其他 可能妨碍其进行独立客观判断的关系，符合《上市公司独立董事管理办法》《上 海证券交易所上市公司自律监管指引第1号——规范运作》中关于独立董事独立 性的相关要求。 苏州天准科技股份有限公司 2025 年 4 月 11 日 苏州天准科技股份有限公司 董事会关于独立董事独立性的专项报告 苏州天准科技股份有限公司（以下简称"公司"）于近日收到独立董事楼佩 煌先生、罗来千先生、许冬冬先生出具的《独立董事独立性情况自查表》，根据 《上市公司独立董事管理办法》《上海证券交易所上市公司自律监管指引第1号 ——规范运作》的有关规定及《公司独立董事工作制度》的相关要求，公司董事 会就独立董事的独立性情况进行评估并出具专项意见如下： ...

证券代码：688003 证券简称：天准科技 公告编号：2025-019 苏州天准科技股份有限公司 一、本次股东股权结构变动的基本情况 苏州天准科技股份有限公司（以下简称"公司"或"天准科技"）实际控制 1 人徐一华先生为优化控制权结构，拟与控股股东苏州青一投资有限公司（以下简 称"青一投资"）签署《财产份额转让协议》。青一投资将其持有的宁波准智创业 投资合伙企业（有限合伙）（以下简称"宁波准智"）的财产份额全部转让给徐一 华先生，青一投资是徐一华先生 100%持股的公司，转让后青一投资不再持有宁 波准智的合伙企业财产份额，徐一华先生将成为宁波准智的普通合伙人并担任宁 波准智的执行事务合伙人，本次变动是公司实际控制人对其间接持股情况进行的 股权结构调整，不属于增持或者减持，不触及要约收购，公司控股股东、实际控 制人均未发生变化。 关于实际控制人间接持股情况变动的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次变动是公司实际控制人徐一华先生对其间接持股情况进行股权结构 调整，即：调整控股股东青一 ...

证券代码：688003 证券简称：天准科技 公告编号：2025-012 苏州天准科技股份有限公司 第四届监事会第十一次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 监事会会议召开情况 苏州天准科技股份有限公司（以下简称"公司"）第四届监事会第十一次会议（以 下简称"本次会议"）于 2025 年 4 月 11 日在公司会议室召开。本次会议的通知于 2025 年 4 月 1 日通过书面及电话等方式送达全体监事。本次会议应参加监事 3 名，实际参加 监事 3 名，会议由监事会主席陆韵枫女士主持，本次会议的召集、召开方式符合《公司 法》等法律、法规、规章、规范性文件及《公司章程》的规定。 二、监事会会议审议情况 本次会议以记名投票方式审议通过了以下议案： 1、审议通过《关于<2024 年度监事会工作报告>的议案》 2024 年度，公司监事会按照《公司法》《公司章程》和《监事会议事规则》等有关 规定，认真履行职责，对公司重大决策和决议的形成、表决程序进行了监督和审查，对 公司依法运作进行了检查。特别是对公司经营 ...

证券代码：688003 证券简称：天准科技 公告编号：2025-011 苏州天准科技股份有限公司 第四届董事会第十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 苏州天准科技股份有限公司（以下简称"公司"）第四届董事会第十二次会 议于 2025 年 4 月 11 日在公司会议室以现场结合通讯表决方式召开。本次会议的 通知于 2025 年 4 月 1 日通过书面及电话等方式送达全体董事。本次会议应参加 董事 7 名，实际参加表决董事 7 名，会议由董事长徐一华先生主持，本次会议的 召集、召开方式符合《公司法》及《公司章程》的规定。 二、董事会会议审议情况 本次会议以记名投票方式审议通过了以下议案： 1、审议通过《关于<2024 年度董事会工作报告>的议案》 公司董事会严格按照有关法律法规、规范性文件以及公司制度规定，切实履 行股东赋予的董事会职责，严格执行股东大会决议，持续完善公司治理，不断规 范公司运营，推动公司持续健康稳定发展，维护了公司和股东的合法权益。 公司独立董事向董事会提交了《公司 2024 年 ...

Financial Performance - The company's operating revenue for 2024 was CNY 1,608,741,148.61, a decrease of 2.38% compared to CNY 1,648,022,914.60 in 2023[22]. - The net profit attributable to shareholders for 2024 was CNY 124,690,602.51, reflecting a significant decline of 42.05% from CNY 215,172,445.39 in 2023[22]. - The basic earnings per share for 2024 decreased to CNY 0.6499, down 42.06% from CNY 1.1217 in 2023[23]. - The company's total assets increased by 12.01% to CNY 3,615,844,123.46 in 2024, compared to CNY 3,228,205,714.64 in 2023[22]. - The net cash flow from operating activities for 2024 was CNY -8,219,890.46, a significant decline from CNY 230,206,737.73 in 2023[22]. - The company's net profit attributable to the parent company was 124.69 million yuan, down 42.05% compared to the previous year[36]. - The gross profit margin for 2024 was 41.17%, remaining stable compared to the previous year[121]. Research and Development - Research and development expenses accounted for 20.79% of operating revenue in 2024, an increase of 1.02 percentage points from 19.77% in 2023[23]. - The company invested CNY 251 million in R&D in 2024, with a total of 724 R&D personnel by the end of the year[41]. - The company has filed 83 new patent applications during the reporting period, including 69 invention patents, and received 38 patent grants[41]. - The company has developed an AI industrial vision detection platform that enhances efficiency in automatic quality inspection and analysis, utilizing a cloud-based training and inference system[71]. - The company has established multiple national and provincial R&D innovation platforms, enhancing its technological capabilities[88]. Corporate Governance - The board of directors has confirmed the authenticity, accuracy, and completeness of the annual report[3]. - The company has not reported any special arrangements for corporate governance[8]. - The company held 2 shareholder meetings, 13 board meetings, and 11 supervisory meetings during the reporting period, ensuring compliance with legal and regulatory requirements[173]. - The company has appointed several independent directors to enhance governance, including Xu Dongdong at Borui Biopharmaceuticals since September 2023[184]. - The company’s internal control evaluation report for 2023 was approved, ensuring effective governance[196]. Market and Industry Trends - The global machine vision and visual-guided robot market is projected to reach $18.88 billion in 2024, growing at a compound annual growth rate of 7.2% from 2024 to 2029[56]. - The machine vision industry in China is rapidly developing, with the country becoming one of the most active regions for machine vision globally[54]. - The demand for high-end PCB products is increasing due to the evolving requirements of downstream applications, driving the development of related technologies and equipment[63]. - The global semiconductor market for measurement equipment is projected to reach $12.8 billion in 2023, with China's market at $4.4 billion, and expected to grow to $15.9 billion and $5.5 billion in 2024 respectively[62]. Risks and Challenges - The company faces risks related to technology R&D and innovation, with a potential impact on client retention if it fails to meet evolving demands[96]. - The company is exposed to foreign exchange risks, particularly with fluctuations in the RMB/USD exchange rate impacting its financial results[115]. - The company faces a risk of tax incentives not being extended, which could significantly impact operational performance[104]. - Accounts receivable balances are expected to increase from 508.29 million yuan in 2022 to 660.75 million yuan in 2024, posing a risk of bad debts impacting operational performance[102]. Strategic Initiatives - The company aims to enhance its market position and shareholder value through continuous development and innovation in machine vision technology[166]. - The company plans to improve its internal governance structure and decision-making mechanisms to enhance operational efficiency and risk management[170]. - The company is focused on exploring new applications and business opportunities related to general artificial intelligence (AGI) to open up new performance growth points[168]. - The company has implemented an employee stock ownership plan and restricted stock incentive plan for four consecutive years to attract and retain core technical talents, enhancing employee cohesion and core competitiveness[169]. Investment and Financial Health - The company plans to apply for a comprehensive credit limit for 2024 from banks[200]. - The company reported a total investment of ¥19,715,199.32 during the reporting period[147]. - The company has a significant stake in Suzhou Tianzhun Software Co., Ltd., with total assets of ¥6,157.46 million and net profit of ¥5,369.03 million[152]. - The overall financial health of the company remains stable, with a focus on aligning compensation with performance metrics[179].

证券代码：688003 证券简称：天准科技 公告编号：2025-014 苏州天准科技股份有限公司 2024 年年度利润分配方案的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 每股分配比例：每10股派发现金红利5.00元（含税），不进行公积金转 增股本，不送红股。 本次利润分配以实施权益分派股权登记日登记的总股本扣减公司回购专 用证券账户中股份为基数，具体日期将在权益分配实施公告中明确。 在实施权益分派的股权登记日前公司总股本扣除公司回购专用账户中股 份的基数发生变动的，拟维持每股分配金额不变，相应调整分配总额，并将 另行公告具体调整情况。 本次利润分配方案不触及《上海证券交易所科创板股票上市规则（2024 年4月修订）》（以下简称《科创板股票上市规则》）第12.9.1条第一款第（八） 项规定的可能被实施其他风险警示的情形。 公司拟向全体股东每10股派发现金红利5.00元（含税）。截至2025年3月31 日，公司总股本193,595,000.00股，回购专用证券账户中股份总数为1,213,000股， ...

Group 1 - The company's operating revenue for 2024 is 1.609 billion yuan, representing a year-on-year decrease of 2.38% [1] - The net profit attributable to shareholders of the listed company is 125 million yuan, showing a year-on-year decline of 42.05% [1] - The company plans to distribute a cash dividend of 5 yuan (including tax) for every 10 shares to all shareholders, based on the total share capital after deducting shares in the repurchase special securities account [1]

Core Insights - The Shanghai Stock Exchange Sci-Tech Innovation Board Artificial Intelligence Index (950180) has shown a positive performance, with a 0.97% increase as of April 11, 2025, and notable gains in constituent stocks such as Chipsea Technology (688595) up 8.19% and Lanqi Technology (688008) up 5.29% [3][4]. Performance Summary - The Sci-Tech AI ETF (588790) has experienced a 0.91% increase, marking its fourth consecutive rise, with a latest price of 0.55 yuan. Over the past three months, the ETF has accumulated a 7.70% increase, ranking 2nd among comparable funds [3][4]. - The ETF's liquidity is strong, with an intra-day turnover of 4.12% and a total transaction volume of 1.08 billion yuan. The average daily transaction volume over the past week is 3.94 billion yuan, leading among comparable funds [3][4]. - In terms of scale, the ETF has seen a significant growth of 26.96 million yuan over the past two weeks, ranking 1st among comparable funds. Additionally, the ETF's share count increased by 36 million shares in the past week, also ranking 1st [3][4]. Return and Risk Metrics - Since its inception, the Sci-Tech AI ETF has achieved a highest monthly return of 15.59%, with an average monthly return of 15.59% and a monthly profit probability of 69.57%. The probability of making a profit over a three-month holding period is 87.50% [4]. - The ETF has a relative drawdown of 0.36% compared to its benchmark since inception, indicating a relatively stable performance [4]. Fee Structure and Tracking Accuracy - The management fee for the Sci-Tech AI ETF is 0.50%, and the custody fee is 0.10%, which are among the lowest in its category [4]. - The ETF has demonstrated high tracking accuracy, with a tracking error of 0.010% over the past month, the best among comparable funds [4]. Top Holdings - As of March 31, 2025, the top ten weighted stocks in the Sci-Tech AI Index account for 70.57% of the index, including Lanqi Technology (688008) and Chipsea Technology (688521) [5][7]. Industry Insights - The semiconductor and AI sectors are expected to accelerate their domestic production processes due to ongoing global trade tensions. Key areas of focus include advancements in semiconductor technology and the growth of domestic AI models [7].

绝对收益方面，截至2025年3月25日，科创板人工智能ETF自成立以来，最高单月回报为15.47%， 最长连涨月数为2个月，最长连涨涨幅为23.91%，涨跌月数比为1/0，上涨月份平均收益率为15.47%，月 盈利百分比为100.00%，月盈利概率为91.18%。回撤方面，截至2025年3月25日，科创板人工智能ETF， 相对基准回撤3.33%。跟踪精度方面，截至2025年3月25日，科创板人工智能ETF今年以来跟踪误差为 0.493%，在可比基金中跟踪精度最高。 相关产品：科创板人工智能ETF（588930） （文章来源：界面新闻） 调整后再出发？科创板人工智能ETF(588930)持续 向上，恒玄科技、芯原股份、中邮科技、天准科技 等领涨 民生证券表示，半导体作为科技产业支柱，经历回调后逐步复苏。AI+自主可控是2025年主要投资 方向，云厂商合作伙伴和端侧落地成AI产业重点。国产替代逻辑强劲，外部环境变化加速自主可控需 求，先进制造、半导体设备及材料国产化迎机遇。先进封装成高成长细分赛道，算力芯片海外代工限制 下，国产先进封装产业链需求弹性显现，COWOS和HBM封装技术成主流，国产厂商积极布局产能及材 ...

Core Viewpoint - Suzhou Tianzhun Technology Co., Ltd. has announced the successful internal validation of its TB2000 wafer defect detection equipment, marking a significant milestone in the domestic production of advanced semiconductor detection equipment [1][2]. Group 1: Product Development and Capabilities - The TB2000 is capable of mass production defect detection for advanced processes of 14nm and below, following the TB1500's breakthrough at the 40nm node [2][3]. - The TB2000 utilizes a fully self-developed high-power wide-spectrum laser excitation plasma light source system, deep ultraviolet high-flux imaging system, high-frequency TDI camera, and ultra-precision high-speed motion platform, combined with AI image processing algorithms to enhance defect detection sensitivity and speed [2][3]. Group 2: Market Position and Strategy - With the launch of TB2000, Tianzhun becomes one of the few manufacturers globally capable of delivering bright field detection equipment for 14nm and below technology nodes, gradually achieving domestic substitution in advanced process defect detection equipment [3][7]. - Tianzhun's product matrix now covers all process nodes for bright field defect detection, with a complete system from TB1000/TB1100 (65-90nm), TB1500 (40nm), to TB2000 (14nm), meeting various customer needs in logic and storage processes [3][5]. Group 3: Industry Outlook - According to the World Semiconductor Association (WICA), the global semiconductor market is expected to reach $718.9 billion by 2025, growing by 13.2%, with the high-end detection equipment market for 14nm and below continuing to grow rapidly due to technological advancements and market demand [5][7]. - Tianzhun aims to build a technological moat covering key detection nodes in chip manufacturing, with a commitment to annual product iterations and continued investment in R&D to overcome technological barriers in the Chinese semiconductor industry [7].